MODERN CONCEPTS OF THE PATHOGENESIS, RISK FACTORS, AND APPROACHES TO THE TREATMENT OF POSTSTROKE DEPRESSION

Open Access Open Access
Restricted Access Subscription Access

Abstract


The review addresses up-do-date data about the pathogenesis and pathophysiology of poststroke depressive conditions. The neurobiological and psychological hypotheses of the development of depressive states after stroke are considered. The significance of brain lesion localization and size, neuromediator disbalance, neurotrophic factor deficit, immune system activation, hypothalamus-pituitary-adrenal system hyperactivity, disturbed neurogenesis, reduced brain blood flow, and personal traits and peculiarities of responses to stress are discussed. The likely trends of the further studies of risk factors of depressive conditions after stroke and of therapy for such conditions are delineated.

S G Belokoskova

Institute of Experimental Medicine

Email: belokoskova.s@yandex.ru
St. Petersburg, Russia

S G Tsikunov

Institute of Experimental Medicine

Email: secikunov@yandex.ru
St. Petersburg, Russia

  1. Концевой В. А., Скворцова В. И., Петрова Е. А., Савина М. А. Депрессия и парадепрессивные расстройства при церебральном инсульте: эпидемиология, патогенез и факторы риска // Журн. неврологии и психиатрии.- 2009.- Т 109, № 8.- С. 4-10.
  2. Скворцова В. И., Петрова Е. А., Брусов О. С. и др. Патогенетические особенности развития постинсультных аффективных расстройств // Журн. неврол. и психиатр.- 2010.- Т 110, № 7.- С. 35-40.
  3. Концевой В. А., Медведев А. В. Сосудистые депрессии // Вестн. РАМН.- 2011.- № 4.- С. 31-38.
  4. Feng C, Fang M., Liu X. Y. The neurobiological pathogenesis of poststroke depression // Scientific World Journal.- 2014.- № 2014.- P. 521349.
  5. Симонов П. В. Лекции о работе головного мозга. Потребностно-информационная теория высшей нервной деятельности.- М.: Институт психологии РАН, 1998.- 98 с.
  6. Хомская Е. Д. Нейропсихология.- СПб.: Питер, 2005.- 496 с.
  7. Констандов Э. А. Психофизиология сознания и бессознательного.- СПб.: Питер, 2004.- 167 с.
  8. Никишина В. Б., Петраш Е. А., Запесоцкая И. В. Восприятие эмоций у больных с ишемическим инсультом // Журн. неврол. и психиатр.- 2015.- Т. 115, № 10.- С. 4-9.
  9. Paradiso S., Ostedgaard K., Vaidya J. et al. Emotional blunting following left basal ganglia stroke: the role of depression and fronto-limbic functional alterations // Psychiatry Res.- 2013.- Vol. 211, № 2.- P. 148-159.
  10. Жаворонкова Е. А. Правши-левши: межполушарная асимметрия биопотенциалов мозга человека.- Краснодар: Экоинвес, 2009.
  11. Fink M., Wadsak W., Savli M. et al. Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET // Neuroimage.- 2009.- Vol. 45, № 2.- Р. 598-605.
  12. Giulietti M., Vivenzio V., Piva F. et al. B. How much do we know about the coupling of G-proteins to serotonin receptors? // Mol. Brain.- 2014.- № 7.- P. 49.
  13. Lesch K. P. Linking emotion to the social brain. The role of the serotonin transporter in human social behavior // EMBO Rep.- 2007.- № 8, Spec No.- S. 24-29.
  14. Lacivita E., Leopoldo M., Berardi F., Perrone R. 5-HT1A receptor, an old target for new therapeutic agents // Curr Top Med. Chem.- 2008.- № 8.- P. 1024-1034.
  15. Martin C. B., Martin V. S., Trigo J. M. et al. 5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence // Int. J. Neuropsychopharmacol.- 2014.- Vol. 18, № 3.- P. 1-37.
  16. Drevets W., Frank E., Price J. et al. PET imaging of serotonin 1A receptor binding in depression // Biol Psychiatr.- 1999.- Vol. 46, № 10.- P. 1375-1387.
  17. Gao H. Q., Zhu H. Y, Zhang Y. Q., Wang L. X. Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: A preliminary report // Clin. Invest. Med.- 2008.- Vol. 31, № 6.- E351-356.
  18. Tully K., Bolshakov V. Y. Emotional enhancement of memory: how norepinephrine enables synaptic plasticity // Mol. Brain.- 2010.- № 3.- P. 15-22.
  19. Oke A., Keller R., Mefford I., Adams R. N. Lateralization of norepinephrine in human thalamus // Science.- 1978.- Vol. 200, № 4348.- P. 1411-1413.
  20. Oquendo M. A., Sullivan G. M., Sudol K. et al. Toward a biosignature for suicide // Am. J. Psychiatry.- 2014.- Vol. 171, № 12.- P. 1259-1277.
  21. Morilak D. A., Barrera G., Echevarria D. J. et al. Role of brain norepinephrine in the behavioral response to stress // Prog. Neuropsychopharmacol. Biol. Psychiatry.- 2005.- Vol. 29, № 8.- P. 1214-1224.
  22. Wise R. A. Dopamine, learning and motivation // Nat Rev Neurosci.- 2004.- № 5.- P. 483-494.
  23. Bradbury A. J., Costall B., Domeney A. M., Naylor R. J. Laterality of dopamine function and neuroleptic action in the amygdala in the rat // Neuropharmacology.- 1985.- Vol. 24, № 12.- P. 1163-1170.
  24. Glick S. D., Ross D. A., Hough L. B. Lateral asymmetry of neurotransmitters in humans brain // Brain Res.- 1982.- Vol. 234, № 1.- P. 53-63.
  25. Larisch R., Meyer W., Klimke A. et al. Left-right asymmetry of striatal dopamine D2 receptors // Nucl. Med. Commun.- 1998.- Vol. 19, № 8.- P. 781-787.
  26. Alex K. D., Pehek E. A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission // Pharmacol Ther.- 2007.- Vol. 113, № 2.- P. 296-320.
  27. Higley M. J., Picciotto M. R. Neuromodulation by acetylcholine: examples from schizophrenia and depression // Curr. Opin Neurobiol.- 2014.- № 29.- P. 88-95.
  28. Fang J., Cheng Q. Etiological mechanisms of post-stroke depression: a review // Neurol Res.- 2009.- Vol. 31, № 9.- P. 904 - 909.
  29. Loubinoux I., Kronenberg G., Endres M. et al. Post-stroke depression: mechanisms, translation and therapy // J. Cell Mol Med.- 2012.- Vol.16, № 9.- P. 1961-1969.
  30. Robinson R. G., Shoemaker W. J., Schlumpf M. Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour // Nature.- 1975.- Vol. 255, № 5506.- P. 332-334.
  31. Vataja R., Pohjasvaara T., Leppavuori A. et al. Magnetic resonance imaging correlates of depression after ischemic stroke // Arch Gen. Psychiatry.- 2001.- Vol. 58, № 10.- P. 925-931.
  32. Aben I., Lodder J., Honig A. et al. Focal or generalized vascular brain damage and vulnerability to depression after stroke: a 1-year prospective follow-up study // International Psychogeriatrics.- 2006.- Vol. 18, № 1.- P. 19-35.
  33. Bhogal S. K., Teasell R., Foley N., Speechley M. Lesion location and poststroke depression: systematic review of the methodological limitations in the literature // Stroke.- 2004.- Vol. 35, № 3.- P. 794-802.
  34. Carson A. J., MacHale S., Allen K et al. Depression after stroke and lesion location: a systematic review // Lancet.- 2000.- Vol. 356, №9224.- P. 122-126.
  35. Alexoupoulos G. S., Meyer B. S., Lavretsky H. et al. Depressive disorders and cerebrovascular disease // Vascular Disease and affective disorders / Eds E. Chiu et al.- London: Martin Dunitz, 2002.- Ch. 9.- P. 127143.
  36. Brodaty H., Withall A., Altendorf A., Sachdev P. S. Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke study // Am. J. Geriatr Psychiatry.- 2007.- Vol.15, № 6.- P. 477-486.
  37. Ramasubbu R. Reletionship between depression and cerebrovascular disease: conceptual issues // J. Affect Dis.- 2000.-Vol. 57, № 13.- P. 1-11.
  38. Robinson R. G., Bloom F. E. Pharmacological treatment following experimental cerebral infarction: implications for understanding psychological symptoms of human stroke // Biol. Psychiatry.- 1977.- Vol. 12, № 5.- P. 669-680.
  39. Winter C., von Rumohr A., Mundt A. et al. Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats // Behav Brain Res.- 2007.- Vol. 184, № 2.- P. 133-141.
  40. Wang S., Zhang Z., Guo Y. et al. Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress: a rat model of post-stroke depression // Psychiatry Research.- 2009.- Vol. 170, № 2-3.- P. 245-251.
  41. Lambert G., Johansson M., Agren H., Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders // Arch Gen. Psychiatry.- 2000.- Vol. 57, № 8.- P. 787-793.
  42. Ruhe H. G., Mason N. S., Schene A. H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies // Mol Psychiatry.- 2007.- Vol. 12.- P. 331-259.
  43. Barton D. A., Esler M., Dawood T. et al. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy // Arch. Gen. Psychiatry.- 2008.- Vol. 65, № 1.- P. 38-46.
  44. Dayan P., Huys Q. J. Serotonin, inhibition, and negative mood // PLoS Comput. Biol.- 2008.- № 4.- e4.
  45. Брусов О. С., Фактор М. И., Катасонов А. Б. Структурные и функциональные изменения в головном мозге при эмоциональных расстройствах: основы нейроциркуляторной и нейротрофической гипотезы депрессии // Журн. неврол. и психиатр.- 2012.- Т. 112, № 7.- С. 83-88.
  46. Sanacora G., Zarate C. A., Krystal J. H. et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders // Nat Rev Drug Discov.- 2008.- № 7.- P. 426-437.
  47. Glodzik-Sobanska L., Slowik A., McHugh P. et al. Single voxel proton magnetic resonance spectroscopy in post-stroke depression // Psychiatry Research.- 2006.- Vol. 148, № 2-3.- P. 111-120.
  48. Noonan K., Carey L. M., Crewther S. G. Meta-analyses indicate associations between neuroendocrine activation, deactivation in neurotrophic and neuroimaging markers in depression after stroke // J. Stroke Cerebrovasc Dis.- 2013.- Vol. 22, № 7.- e124-135.
  49. Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders // Neuropsychopharmacology.- 2008.- № 33.- P. 73-83.
  50. Duman R. S., Monteggia L. M. A neurotrophic model for stress-related mood disorders // Biol Psychiatry.- 2006.- Vol. 59, № 12.- P. 1116-11127.
  51. You Z., Luo C., Zhang W. et al. Pro- and anti-inflammatory cytokines expression in rat’s brain and spleen exposed to chronic mild stress: involvement in depression // Behav Brain Res.- 2011.- Vol. 225, № 1.- P. 135-141.
  52. Leonard B. E. The concept of depression as a dysfunction of the immune system // Current Immunology Reviews.- 2010.- Vol. 6, № 3.- P.205-212.
  53. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation // Nature Medicine.- 2011.- Vol. 17, № 7.- P. 796-808.
  54. Tsigos C., Chrousos G. P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress // J. Psychosom Res.- 2002.- Vol. 53, № 4.- P. 865-871.
  55. Felger J. C., Alagbe O., Hu F. et al. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression // Biol. Psychiatry.- 2007.- Vol. 62, № 11.- P. 1324-1333.
  56. Zhang R. L., LeTourneau Y., Gregg S. R. et al. Neuroblast division during migration toward the ischemic striatum: a study of dynamic migratory and proliferative characteristics of neuroblasts from the subventricular zone // J. Neurosci.- 2007.- Vol. 27, № 12.- P. 3157-3162.
  57. Zunszain P. A., Anacker C., Cattaneo A. et al. Glucocorticiids, cytokines and brain abnormalities in depression // Prog. Neuropsychopharmacol Biol. Psychiatry.- 2011.- Vol. 35, № 3.- P. 722-729.
  58. Seguin J. A., Brennan J., Mangano E., Hayley S. Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration // Neuropsychiatr. Dis. Treat.- 2009.- Vol. 5, № 1.- P. 5-14.
  59. Yang L., Zhang Z., Sun D. et al. Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke // Int J. Geriatr Psychiatry.- 2011.- Vol. 26, № 5.- P. 495-502.
  60. Reimold M., Knobel A., Rapp M. A. et al. Central serotonin transporter levels are associated with stress hormone response and anxiety // Psychopharmacology.- 2011.- Vol. 213, № 2-3.- P. 563-572.
  61. Anisman H., Gibb J., Hayley S. Influence of continuous infusion of interleukin-1p on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression // Psychopharmacology.- 2008.- Vol. 199, № 2.- P. 231-244.
  62. De Kloet E. R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease // Nat Rev Neurosci.- 2005.- № 6.- P. 463-475.
  63. Kohen R., Cain K. C., Mitchell P. H. et al. Association of serotonin transporter gene polymorphisms with poststroke depression // Arch Gen. Psychiatry.- 2008.-Vol. 65, № 11.- P. 1296-1302.
  64. Grasso M. G., Pantano P., Ricci M. et al. Mesial temporal cortex hypoperfusion is associated with depression in subcortical stroke // Stroke.- 1994.- Vol. 25, № 5.- P. 980-985.
  65. Kimura M., Shimoda K., Mizumura S. et al. Regional cerebral blood flow in vascular depression assessed by 123I-IMP SPECT // J. Nippon Med. Sch.- 2003.- Vol. 70, № 4.- P. 321-326.
  66. Drevets W. C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression // Prog Brain Res.- 2000.- № 126.- P. 413-431.
  67. Белокоскова С. Г., Степанов И. И., Цикунов С. Г. Роль локализации инсульта и конституционально-личностных особенностей больных как факторов риска развития постинсультных депрессий // Мед. акад. журн.- 2011.- Т. 11, № 2.- С. 71-76.
  68. Hwang S. I., Choi K., Park O. T. et al. Correlations between Pre-morbid Personality and Depression Scales in Stroke Patients // Ann. Rehabil. Med.- 2011.- Vol. 35, № 3.- P. 328-336.
  69. Shin T. K., Kang M. S., Lee H. Y. et al. Fluoxetine and sertraline attenuate postischemic brain injury in mice // Korean J. Physiol. Pharmacol.- 2009.- № 13.- р. 257-263.
  70. Белокоскова С. Г., Степанов И. И., Цикунов С. Г. Агонист V2-рецепторов вазопрессина редуцирует депрессивные расстройства у постинсультных больных // Вестник РАМН.- 2012.- № 4. -С. 40-44.

Views

Abstract - 25

PDF (Russian) - 0

PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2016 Belokoskova S.G., Tsikunov S.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.